SAS isn't TGA "go ahead". SAS requires an individual application by the Prescriber for clinical use by an individual. This application has to be assessed and approved by the TGA if individually clinically justified. I only asked as I would be surprised if "Spongieman" was actually one of those few National individuals. Only a couple of Prescribers have been announced so far.... Don't get me wrong, I think this is a great opportunity and product but I hope that all those on this forum are honest with their content...... hype...... pumping (pardon the punn).
SAS isn't TGA "go ahead". SAS requires an individual application...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.005(0.29%) |
Mkt cap ! $146.6M | |||
| Open | High | Low | Value | Volume |
| $1.76 | $1.78 | $1.70 | $519.8K | 300.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 784 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| LTP (ASX) Chart |